Target intelligence / Profile preview

Zinc finger and BTB domain-containing protein 43 (ZBTB43)

Target
ZBTB43
Molecular classification
Transcription factor, Zinc finger protein, BTB domain-containing protein
01

Overview

Zinc finger and BTB domain-containing protein 43 (ZBTB43) is a member of the ZBTB protein family characterized by Cys2-His2 (C2H2) zinc finger motifs and a BTB domain[1][3][7]. ZBTB43 functions as a sequence-specific transcription factor that binds to purine-pyrimidine repeat (PPR) rich DNA sequences capable of forming Z-DNA, an alternative left-handed DNA structure[1][3][5][6]. ZBTB43 acts to resolve these Z-DNA structures, converting them back to the canonical right-handed B-DNA, thereby safeguarding genomic and epigenomic integrity in male germ cells (prospermatogonia) during development[1][3][5][6]. This remodeling is critical for enabling de novo DNA methylation by DNA methyltransferases such as DNMT3A, preventing DNA double-strand breaks (DSBs), and protecting against large genomic deletions or rearrangements that could lead to heritable mutations or cancer[1][3][5][6]. ZBTB43 is not a classical therapeutic target such as a receptor, enzyme, or transporter but rather plays a specialized role in chromatin regulation and genome maintenance in the germ line[2][3][6][7]. There are no known drugs that directly target ZBTB43, and no established clinical biomarkers for its function at this time. Inactivation or loss of ZBTB43 activity is associated with increased risk of DNA breaks and genomic instability[3][5][6].

Other names
KIAA0414ZBTB22BZNF297BZNF-XFLJ22470zinc finger and BTB domain-containing protein 22Bzinc finger protein 297BZnF-x
02

Biological functions

Maintenance of genomic stabilityDNA methylation regulationChromatin remodelingSequence-specific double-stranded DNA bindingRNA polymerase III general transcription initiation factor binding
03

Disease associations

Cancer (genome rearrangement/mutagenesis risk)Germline mutation preventionOther (potential relevance to genome instability disorders)
04

Safety considerations

Potential genomic instability and cancer risk if inactivated or mutated

Beyond the preview

Go deeper on Zinc finger and BTB domain-containing protein 43 (ZBTB43).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger and BTB domain-containing protein 43 (ZBTB43).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call